United Therapeutics Corp.(NASDAQ : UTHR)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Other
|SAVA||Cassava Sciences, Inc.||4.66%||83.71||0.0%||$530.92m|
|VRX||Valeant Pharmaceuticals International, Inc.||-6.54%||27.71||14.1%||$163.05m|
|HZNP||Horizon Therapeutics Plc||-0.38%||99.41||5.5%||$111.54m|
|JAZZ||Jazz Pharmaceuticals Plc||-0.63%||169.63||2.2%||$86.44m|
|PRGO||Perrigo Co. Plc||-0.08%||48.29||6.9%||$49.62m|
|ENDP||Endo International Plc||-4.20%||4.79||8.6%||$44.39m|
|BHC||Bausch Health Cos., Inc.||-6.48%||27.73||0.0%||$41.92m|
|UTHR||United Therapeutics Corp.||-0.88%||178.28||14.0%||$38.47m|
|SAGE||SAGE Therapeutics, Inc.||-2.56%||42.26||7.6%||$32.22m|
|NTEC||Intec Parent, Inc.||-1.12%||10.88||0.0%||$31.43m|
|IRWD||Ironwood Pharmaceuticals, Inc.||-3.26%||12.84||9.6%||$24.21m|
|AXSM||Axsome Therapeutics, Inc.||-0.95%||49.84||1.9%||$17.95m|
United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It also involves in the research and development of new indications and delivery devices for its product and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.